State Rx Monitoring Programs Curb Opioid Overdose Deaths

49 states (Missouri is the exception) have drug monitoring programs in an effort to curb overdose deaths from prescription opioids, and the efforts appear to be working well.

These programs are designed to track patients at high-risk for abuse and addiction, as well as keep tabs on doctors who give out a lot of opioid prescriptions.

Researchers at the Vanderbilt University School of Medicine in Nashville, Tenn., found that these monitoring programs helped to prevent about 1 opioid painkiller overdose death every two hours. Their findings, published in Health Affairs, were based on an analysis of mortality data and data on states’ prescription drug monitoring programs from 1999 to 2013.

The analysis also showed that states with the strongest programs saw reductions of 1.55 fewer deaths per 100,000 people compared to states without such programs.

In the case of Missouri, the study’s authors estimate that if the state implemented a monitoring program and other states enhanced existing programs with more robust features, there would be more than 600 fewer overdose deaths nationwide this year, or about two deaths prevented each day.

“Congress is currently considering legislation to bolster the U.S. public health response to the opioid epidemic,” lead author Stephen Patrick, MD, MPH, assistant professor of Pediatrics and Health Policy in the Division of Neonatology at Monroe Carell Jr. Children’s Hospital at Vanderbilt, said in a statement. “Our findings suggest that investments in upgraded prescription drug monitoring programs will pay dividends in lives saved.”

Between 1999 and 2014, more than 165,000 people died from prescription opioid overdoses, according to the U.S. Centers for Disease Control and Prevention.

Jonathan Block

Jonathan Block

Jonathan Block is an associate editor at BioCentury, which provides news and information about the biotechnology and pharmaceutical industries. Prior to joining BioCentury in 2019, Jonathan worked for MedShadow as content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.

Did you find this article helpful?

No votes so far! Be the first to rate this post.

Latest News

Belviq, ActiPatch, Free Samples, Dollar Tree Drugs

Belviq, ActiPatch, Free Samples, Dollar Tree Drugs

We knew it was too good to be true – free and cheap drugs aren’t worth it. Also, taking a magic pill to lose weight could give you cancer (!). One ray of sunshine: a pain therapy device using shortwave is now available over-the-counter. Have a lovely Valentine’s Day! Be…

Flouride, PPIs, Breast Density and Prostate Cancer

Flouride, PPIs, Breast Density and Prostate Cancer

Startling news about fluoride, a study encourages more limites use of PPIs, does knowing the density of your breasts matter, and vegetables aren’t helpful in warding off prostate cancer (darn).  Be Well.  Fluoride and Pregnancy The medical community was shocked at the conclusions of two new studies on fluoride’s effect…

  • Advertisement